Skip to main content

Table 3 Overall response of target lesions according to RECIST v1.0 by CPS

From: External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26

 

CPS A

CPS B

Best response (N)

14

4

 PR

8 (57%)

2 (50%)

 SD

4 (29%)

1 (25%)

 NA

2 (14%)

1 (25%)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us